Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Signs and symptoms  



1.1  Complications  







2 Causes  



2.1  Primary glomerulonephrosis  





2.2  Secondary glomerulonephrosis  



2.2.1  By histologic pattern  







2.3  Genetics  







3 Pathophysiology  





4 Diagnosis  



4.1  Classification  





4.2  Differential diagnosis  







5 Treatment  



5.1  Symptomatic  





5.2  Kidney damage  







6 Prognosis  





7 Epidemiology  





8 References  





9 External links  














Nephrotic syndrome






العربية
Català
Čeština
Deutsch
ދިވެހިބަސް
Eesti
Ελληνικά
Español
Euskara
فارسی
Français
Gaeilge
Galego

Hausa
Հայերեն
Hrvatski
Bahasa Indonesia
Italiano
עברית
Қазақша
Македонски

Nederlands

ି
Oʻzbekcha / ўзбекча
پښتو
Polski
Português
Română
Русский
Simple English
Slovenčina
Српски / srpski
Srpskohrvatski / српскохрватски
Suomi
Svenska
Татарча / tatarça

Türkçe
Українська

 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Nephrotic syndrome
Microscopic image of diabetic glomerulosclerosis, the main cause of nephrotic syndrome in adults.
SpecialtyNephrology
SymptomsSwelling, weight gain, feeling tired, foamy urine[1]
ComplicationsBlood clots, infections, high blood pressure[1]
CausesFocal segmental glomerulosclerosis, membranous nephropathy, minimal change disease, diabetes, lupus[1][2]
Diagnostic methodUrine testing, kidney biopsy[1]
Differential diagnosisNephritic syndrome, cirrhosis, severe malnutrition[2]
TreatmentDirected at underlying cause[1]
Frequency5 per 100,000 per year[3][4]

Nephrotic syndrome is a collection of symptoms due to kidney damage. This includes protein in the urine, low blood albumin levels, high blood lipids, and significant swelling. Other symptoms may include weight gain, feeling tired, and foamy urine. Complications may include blood clots, infections, and high blood pressure.[1]

Causes include a number of kidney diseases such as focal segmental glomerulosclerosis, membranous nephropathy, and minimal change disease.[1][2] It may also occur as a complication of diabetes, lupus, or amyloidosis. The underlying mechanism typically involves damage to the glomeruli of the kidney. Diagnosis is typically based on urine testing and sometimes a kidney biopsy.[1] It differs from nephritic syndrome in that there are no red blood cells in the urine.[2]

Treatment is directed at the underlying cause. Other efforts include managing high blood pressure, high blood cholesterol, and infection risk. A low-salt diet and limiting fluids are often recommended.[1] About 5 per 100,000 people are affected per year.[3][4] The usual underlying cause varies between children and adults.[4]

Signs and symptoms[edit]

Nephrotic syndrome is usually accompanied by retention of water and sodium. The degree to which this occurs can vary between slight edema in the eyelids that decreases during the day, to affecting the lower limbs, to generalized swelling, to full blown anasarca.[5]

Nephrotic syndrome is characterized by large amounts of proteinuria (>3.5 g per 1.73 m2 body surface area per day,[6] or > 40 mg per square meter body surface area per hour in children), hypoalbuminemia (< 3.5 g/dl), hyperlipidaemia, and edema that begins in the face. Lipiduria (lipids in urine) can also occur, but is not essential for the diagnosis of nephrotic syndrome.

A few other characteristics seen in nephrotic syndrome are:

The main signs of nephrotic syndrome are:[8]

Complications[edit]

Nephrotic syndrome can be associated with a series of complications that can affect an individual's health and quality of life:[15]

Causes[edit]

Histological image of a normal kidney glomerulus. It is possible to see a glomerulus in the centre of the image surrounded by kidney tubules.

Nephrotic syndrome has many causes and may either be the result of a glomerular disease that can be either limited to the kidney, called primary nephrotic syndrome (primary glomerulonephrosis), or a condition that affects the kidney and other parts of the body, called secondary nephrotic syndrome.[20]

Primary glomerulonephrosis[edit]

Primary causes of nephrotic syndrome are usually described by their histology:[21]

They are considered to be "diagnoses of exclusion", i.e. they are diagnosed only after secondary causes have been excluded.

Secondary glomerulonephrosis[edit]

Diabetic glomerulonephritis in a person with nephrotic syndrome.

Secondary causes of nephrotic syndrome have the same histologic patterns as the primary causes, though they may exhibit some differences suggesting a secondary cause, such as inclusion bodies.[24] They are usually described by the underlying cause, such as:[citation needed]

By histologic pattern[edit]

Membranous nephropathy (MN)

Focal segmental glomerulosclerosis (FSGS)[26]

Minimal change disease (MCD)[26]

Membranoproliferative Glomerulonephritis

Genetics[edit]

Over 50 mutations are known to be associated with this condition.[28][29]

Non-Genetic

There is no known genetic cause for idiopathic nephrotic syndrome. This is thought to be caused by a hitherto unknown circulating permeability factor that travels in the circulation to the podocyte within the glomerulus of the kidney. This circulating factor damages the podocyte which changes its structure. The podocytes are now less able to restrict urinary protein loss. Despite not knowing the specific indentity of the circulating factor, scientists are learning more about it. It is thought to be either T cell or B cell derived,[30][31] hence why staroid treatment can be effective for some patients. There is also evidence that the circulating factor could be signalling via the PAR-1 receptro on the podocytes.[32]

Pathophysiology[edit]

Drawing of the kidney glomerulus.

The kidney glomerulus filters the blood that arrives at the kidney. It is formed of capillaries with small pores that allow small molecules to pass through that have a molecular weight of less than 40,000 daltons,[33] but not larger macromolecules such as proteins.

In nephrotic syndrome, the glomeruli are affected by an inflammation or a hyalinization (the formation of a homogenous crystalline material within cells) that allows proteins such as albumin, antithrombin or the immunoglobulins to pass through the cell membrane and appear in urine.[15]

Albumin is the main protein in the blood that is able to maintain an oncotic pressure, which prevents the leakage of fluid into the extracellular medium and the subsequent formation of edemas.[citation needed]

As a response to hypoproteinemia the liver commences a compensatory mechanism involving the synthesis of proteins, such as alpha-2 macroglobulin and lipoproteins.[15] An increase in the latter can cause the hyperlipidemia associated with this syndrome.

Diagnosis[edit]

Urinalysis will be able to detect high levels of proteins and occasionally microscopic haematuria.
Ultrasound of a kidney with nephrotic syndrome. There is a hyperechoic kidney without demarcation of the cortex and medulla.[34]

Along with obtaining a complete medical history, a series of biochemical tests are required in order to arrive at an accurate diagnosis that verifies the presence of the illness. In addition, imaging of the kidneys (for structure and presence of two kidneys) is sometimes carried out, and/or a biopsy of the kidneys. The first test will be a urinalysis to test for high levels of proteins,[35] as a healthy subject excretes an insignificant amount of protein in their urine. The test will involve a 24-hour bedside urinary total protein estimation. The urine sample is tested for proteinuria (>3.5 g per 1.73 m2 per 24 hours). It is also examined for urinary casts, which are more a feature of active nephritis. Next a blood screen, comprehensive metabolic panel (CMP) will look for hypoalbuminemia: albumin levels of ≤2.5 g/dL (normal=3.5-5 g/dL). Then a Creatinine Clearance CCr test will evaluate kidney function particularly the glomerular filtration capacity.[36] Creatinine formation is a result of the breakdown of muscular tissue, it is transported in the blood and eliminated in urine. Measuring the concentration of organic compounds in both liquids evaluates the capacity of the glomeruli to filter blood. Electrolytes and urea levels may also be analysed at the same time as creatinine (EUC test) in order to evaluate kidney function. A lipid profile will also be carried out as high levels of cholesterol (hypercholesterolemia), specifically elevated LDL, usually with concomitantly elevated VLDL, is indicative of nephrotic syndrome.[citation needed]

A kidney biopsy may also be used as a more specific and invasive test method. A study of a sample's anatomical pathology may then allow the identification of the type of glomerulonephritis involved.[35] However, this procedure is usually reserved for adults as the majority of children experience minimal change disease that has a remission rate of 95% with corticosteroids.[37] A biopsy is usually only indicated for children that are corticosteroid resistant as the majority have focal and segmental glomeruloesclerosis.[37]

Further investigations are indicated if the cause is not clear including analysis of auto-immune markers (ANA, ASOT, C3, cryoglobulins, serum electrophoresis), or ultrasound of the whole abdomen.

Classification[edit]

A broad classification of nephrotic syndrome based on underlying cause:

Nephrotic
syndrome
PrimarySecondary

Nephrotic syndrome is often classified histologically:

Nephrotic syndrome
MCDFSGSMGNMPGN

Differential diagnosis[edit]

Some symptoms that are present in nephrotic syndrome, such as edema and proteinuria, also appear in other illnesses. Therefore, other pathologies need to be excluded in order to arrive at a definitive diagnosis.[38]

Acute fluid overload can cause edema in someone with kidney failure. These people are known to have kidney failure, and have either drunk too much or missed their dialysis. In addition, when Metastatic cancer spreads to the lungs or abdomen it causes effusions and fluid accumulation due to obstruction of lymphatic vessels and veins, as well as serous exudation.

Treatment[edit]

The treatment of nephrotic syndrome can be symptomatic or can directly address the injuries caused to the kidney.[citation needed]

Symptomatic[edit]

The objective of this treatment is to treat the imbalances brought about by the illness:[44] edema, hypoalbuminemia, hyperlipidaemia, hypercoagulability and infectious complications.

  1. Analyse haemoglobin and haematocrit levels.
  2. A solution of 25% albumin is used that is administered for only 4 hours in order to avoid pulmonary edema.
  3. Haemoglobin and haematocrit levels are analysed again: if the haematocrit value is less than the initial value (a sign of correct expansion) the diuretics are administered for at least 30 minutes. If the haematocrit level is greater than the initial one this is a contraindication for the use of diuretics as they would increase said value.
It may be necessary to give a person potassium or require a change in dietary habits if the diuretic drug causes hypokalaemia as a side effect.

In addition to these key imbalances, vitamin D and calcium are also taken orally in case the alteration of vitamin D causes severe hypocalcaemia, this treatment has the goal of restoring physiological levels of calcium in the person.[56]

Kidney damage[edit]

The treatment of kidney damage may reverse or delay the progression of the disease.[44] Kidney damage is treated by prescribing drugs:

The susceptibility testing in vitro to glucocorticoids on the person's peripheral blood mononuclear cells is associated with the number of new cases of not optimal clinical responses: the most sensitive people in vitro have shown a higher number of cases of corticodependence, while the most resistant people in vitro showed a higher number of cases of ineffective therapy.[59]

Prognosis[edit]

The prognosis for nephrotic syndrome under treatment is generally good although this depends on the underlying cause, the age of the person and their response to treatment. It is usually good in children, because minimal change disease responds very well to steroids and does not cause chronic kidney failure. Any relapses that occur become less frequent over time;[60] the opposite occurs with mesangiocapillary glomerulonephritis, in which the kidney fails within three years of the disease developing, making dialysis necessary and subsequent kidney transplant.[60] In addition children under the age of 5 generally have a poorer prognosis than prepubescents, as do adults older than 30 years of age as they have a greater risk of kidney failure.[61]

Other causes such as focal segmental glomerulosclerosis frequently lead to end stage kidney disease. Factors associated with a poorer prognosis in these cases include level of proteinuria, blood pressure control and kidney function (GFR).[citation needed]

Without treatment nephrotic syndrome has a very bad prognosis especially rapidly progressing glomerulonephritis, which leads to acute kidney failure after a few months.[citation needed]

Epidemiology[edit]

Nephrotic syndrome can affect any age, although it is mainly found in adults with a ratio of adults to children of 26 to 1.[62]

The syndrome presents in different ways in the two groups: the most frequent glomerulopathy in children is minimal change disease (66% of cases), followed by focal segmental glomerulosclerosis (8%) and mesangiocapillary glomerulonephritis (6%).[24] In adults the most common disease is mesangiocapillary glomerulonephritis (30-40%), followed by focal and segmental glomeruloesclerosis (15-25%) and minimal change disease (20%). The latter usually presents as secondary and not primary as occurs in children. Its main cause is diabetic nephropathy.[24] It usually presents in a person from their 40s or 50s. Of the glomerulonephritis cases, approximately 60% to 80% are primary, while the remainder are secondary.[62]

There are also differences in epidemiology between the sexes, the disease is more common in men than in women by a ratio of 2 to 1.[62]

The epidemiological data also reveals information regarding the most common way that symptoms develop in people with nephrotic syndrome:[62] spontaneous remission occurs in up to 20% or 30% of cases during the first year of the illness. However, this improvement is not definitive as some 50% to 60% of people with Nephrotic syndrome die and/or develop chronic kidney failure 6 to 14 years after this remission. On the other hand, between 10% and 20% of people have continuous episodes of remissions and relapses without dying or jeopardizing their kidney. The main causes of death are cardiovascular, as a result of the chronicity of the syndrome, and thromboembolic accidents.

References[edit]

  1. ^ a b c d e f g h i "Nephrotic Syndrome in Adults". National Institute of Diabetes and Digestive and Kidney Diseases. February 2014. Retrieved 9 November 2017.
  • ^ a b c d Ferri, Fred F. (2017). Ferri's Clinical Advisor 2018 E-Book: 5 Books in 1. Elsevier Health Sciences. p. 889. ISBN 9780323529570.
  • ^ a b Kher, Kanwal; Schnaper, H. William; Greenbaum, Larry A. (2016). Clinical Pediatric Nephrology, Third Edition. CRC Press. p. 307. ISBN 9781482214635.
  • ^ a b c Kelly, Christopher R.; Landman, Jaime (2012). The Netter Collection of Medical Illustrations - Urinary System e-Book. Elsevier Health Sciences. p. 101. ISBN 978-1455726561.
  • ^ Behrman, Richard E.; Robert M Kliegman; Hal B. Jenson (2008). Nelson Tratado de Pediatria (in Spanish). Elsevier, España. p. 1755. ISBN 978-8481747478.
  • ^ "Electronic Learning Module for Kidney and Urinary Tract Diseases". Archived from the original on 2008-12-20. Retrieved 2015-12-25.
  • ^ Freedberg, Irwin M.; et al., eds. (2003). Fitzpatrick's dermatology in general medicine (6th ed.). New York, NY [u.a.]: McGraw-Hill. p. 659. ISBN 0-07-138076-0.
  • ^ "Manifestaciones clínicas del síndrome nefrótico" (PDF). See table 4.2. Archived from the original (PDF) on 24 September 2015. Retrieved 12 Sep 2008.
  • ^ a b García - Conde, J.; Merino Sánchez, J.; González Macías, J. (1995). "Fisiopatología glomerular". Patología General. Semiología Clínica y Fisiopatología. McGraw - Hill Interamericana. ISBN 8448600932.
  • ^ Parra Herrán, Carlos Eduardo; Castillo Londoño, Juan Sebastián; López Panqueva, Rocío del Pilar; Andrade Pérez, Rafael Enrique. "Síndrome nefrótico y proteinuria en rango no nefrótico". Retrieved 2008-09-14.
  • ^ "Valores normales de proteína en orina de 24 horas". Retrieved 24 August 2012.
  • ^ Davis, K; Kohli, P (15 July 2019). "What to know about hyperlipidemia". Medical News Today. Retrieved 1 July 2021.
  • ^ "Case Based Pediatrics Chapter". Hawaii.edu. Retrieved 23 August 2018.
  • ^ Klahr S, Tripathy K, Bolanos O (1967). "Qualitative and Quantitative Analysis of Urinary Lipids in the Nephrotic Syndrome". J. Clin. Invest. 46 (9): 1475–81. doi:10.1172/JCI105639. PMC 292893. PMID 6036540.
  • ^ a b c Álvarez, Sandalio Durán (1999). "Complicaciones agudas del síndrome nefrótico" [Acute complications of nephrotic syndrome]. Revista Cubana de Pediatría (in Spanish). 7 (4).
  • ^ Ruiz, S.; Soto, S.; Rodado, R.; Alcaraz, F.; López Guillén, E. (September 2007). "Peritonitis bacteriana espontánea como forma de presentación de síndrome nefrótico idiopático en un adulto de raza negra" [Spontaneous bacterial peritonitis as form of presentation of idiophatic nephrotic syndrome in an adult black race]. Anales de Medicina Interna (in Spanish). 24 (9): 442–4. doi:10.4321/s0212-71992007000900008. PMID 18198954.
  • ^ Zollo, Anthony J (2005). "Nefrología". Medicina interna. Secretos (Cuarta ed.). Elsevier España. p. 283. ISBN 8481748862.
  • ^ a b "Balance de nitrógeno y equilibrio nitrogenado". Retrieved 8 Sep 2008. It occurs during renal pathologies, during fasting, in eating disorders or during heavy physical exercise.
  • ^ "Cushing's Syndrome". The Lecturio Medical Concept Library. Retrieved 11 July 2021.
  • ^ "Ascites". The Lecturio Medical Concept Library. Retrieved 1 July 2021.
  • ^ "Descripción histológica de las glomerulonefritis ideopáticas". Retrieved 8 Sep 2008.
  • ^ a b "Patient information: The nephrotic syndrome (Beyond the Basics)". Retrieved 2013-06-28.
  • ^ James W Lohr, MD. "Rapidly progressive glomerulonephritis". Retrieved 2013-06-28.
  • ^ a b c "Frecuencia de las glomerulonefritis y causas de las glomerulonefritis secundarias". Retrieved 8 Sep 2008.[permanent dead link]
  • ^ "Fármacos que pueden producir síndrome nefrótico". Retrieved 8 Sep 2008.
  • ^ a b Fogo AB, Bruijn JA. Cohen AH, Colvin RB, Jennette JC. Fundamentals of Renal Pathology. Springer. ISBN 978-0-387-31126-5.
  • ^ a b "Nephrotic syndrome". Archived from the original on 2013-04-23. Retrieved 2016-05-21.
  • ^ Bierzynska, Agnieszka; McCarthy, Hugh J.; Soderquest, Katrina; Sen, Ethan S.; Colby, Elizabeth; Ding, Wen Y.; Nabhan, Marwa M.; Kerecuk, Larissa; Hegde, Shivram; Hughes, David; Marks, Stephen; Feather, Sally; Jones, Caroline; Webb, Nicholas J.A.; Ognjanovic, Milos (April 2017). "Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management". Kidney International. 91 (4): 937–947. doi:10.1016/j.kint.2016.10.013. hdl:1983/c730c0d6-5527-435a-8c27-a99fd990a0e8. ISSN 0085-2538. PMID 28117080. S2CID 4768411.
  • ^ Braun, Daniela A.; Lovric, Svjetlana; Schapiro, David; Schneider, Ronen; Marquez, Jonathan; Asif, Maria; Hussain, Muhammad Sajid; Daga, Ankana; Widmeier, Eugen; Rao, Jia; Ashraf, Shazia; Tan, Weizhen; Lusk, C. Patrick; Kolb, Amy; Jobst-Schwan, Tilman; Schmidt, Johanna Magdalena; Hoogstraten, Charlotte A.; Eddy, Kaitlyn; Kitzler, Thomas M.; Shril, Shirlee; Moawia, Abubakar; Schrage, Kathrin; Khayyat, Arwa Ishaq A.; Lawson, Jennifer A.; Gee, Heon Yung; Warejko, Jillian K.; Hermle, Tobias; Majmundar, Amar J.; Hugo, Hannah; Budde, Birgit; Motameny, Susanne; Altmüller, Janine; Noegel, Angelika Anna; Fathy, Hanan M.; Gale, Daniel P.; Waseem, Syeda Seema; Khan, Ayaz; Kerecuk, Larissa; Hashmi, Seema; Mohebbi, Nilufar; Ettenger, Robert; Serdaroğlu, Erkin; Alhasan, Khalid A.; Hashem, Mais; Goncalves, Sara; Ariceta, Gema; Ubetagoyena, Mercedes; Antonin, Wolfram; Baig, Shahid Mahmood; Alkuraya, Fowzan S.; Shen, Qian; Xu, Hong; Antignac, Corinne; Lifton, Richard P.; Mane, Shrikant; Nürnberg, Peter; Khokha, Mustafa K.; Hildebrandt, Friedhelm (4 September 2018). "Mutations in multiple components of the nuclear pore complex cause nephrotic syndrome". Journal of Clinical Investigation. 128 (10): 4313–4328. doi:10.1172/JCI98688. PMC 6159964. PMID 30179222.
  • ^ van den Berg, José G.; Weening, Jan J. (2004-07-27). "Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome". Clinical Science. 107 (2): 125–136. doi:10.1042/cs20040095. ISSN 0143-5221. PMID 15157184.
  • ^ May, Carl J.; Welsh, Gavin I.; Chesor, Musleeha; Lait, Phillipa J.; Schewitz-Bowers, Lauren P.; Lee, Richard W. J.; Saleem, Moin A. (2019-10-01). "Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation". American Journal of Physiology. Renal Physiology. 317 (4): F913–F921. doi:10.1152/ajprenal.00093.2019. ISSN 1931-857X. PMC 6843047. PMID 31339775.
  • ^ May, Carl J.; Chesor, Musleeha; Hunter, Sarah E.; Hayes, Bryony; Barr, Rachel; Roberts, Tim; Barrington, Fern A.; Farmer, Louise; Ni, Lan; Jackson, Maisie; Snethen, Heidi; Tavakolidakhrabadi, Nadia; Goldstone, Max; Gilbert, Rodney; Beesley, Matt (March 2023). "Podocyte protease activated receptor 1 stimulation in mice produces focal segmental glomerulosclerosis mirroring human disease signaling events". Kidney International. 104 (2): 265–278. doi:10.1016/j.kint.2023.02.031. ISSN 0085-2538. PMID 36940798. S2CID 257639270.
  • ^ "Apuntes de fisiopatología de sistemas". Archived from the original on 2008-09-08. Retrieved 8 Sep 2008.
  • ^ Hansen, Kristoffer; Nielsen, Michael; Ewertsen, Caroline (23 December 2015). "Ultrasonography of the Kidney: A Pictorial Review". Diagnostics. 6 (1): 2. doi:10.3390/diagnostics6010002. PMC 4808817. PMID 26838799.
  • ^ a b "Nefrología y urología". Retrieved 12 Sep 2008.
  • ^ "El diagnóstico del síndrome nefrótico". Retrieved 12 Sep 2008.
  • ^ a b Voguel S, Andrea; Azócar P, Marta; Nazal Ch, Vilma; Salas del C, Paulina (June 2006). "Indicaciones de la biospsia renal en niños". Revista Chilena de Pediatría. 77 (3): 295–303. doi:10.4067/S0370-41062006000300011. Retrieved 2008-09-14.
  • ^ "Diagnóstico diferencial en el síndrome nefrótico". Archived from the original on 2009-03-06. Retrieved 2008-09-14.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  • ^ Harold Friedman, H (2001). "General problems". Problem-oriented Medical Diagnosis (Seventh ed.). Lippincott Williams & Wilkins. pp. 3 and 4. ISBN 0-7817-2909-2.
  • ^ "El edema en la insuficiencia cardíaca". Retrieved 2008-09-14.
  • ^ a b Goldman, Lee; Braunwald, Eugene (2000). "Edemas". Cardiología en atención primaria. Harcourt. pp. 114–117. ISBN 8481744328.
  • ^ Rivera, F; Egea, J.J; Jiménez del Cerro, L.A; Olivares, J. "La proteinuria en el mieloma múltiple". Retrieved 2008-09-14.[permanent dead link]
  • ^ Bustillo Solano, Emilio. "Relación de la proteinuria con el nivel de hemoglobina glicosilada en los diabéticos". Archived from the original on 2008-09-14. Retrieved 2008-09-14.
  • ^ a b Curtis, Michael J.; Page, Clive P.; Walker, Michael J.A; Hoffman, Brian B. (1998). "Fisiopatología y enfermedades renales". Farmacología integrada. Harcourt. ISBN 8481743402.
  • ^ Saz Peiro, Pablo. "El reposo prolongado" (PDF). Archived from the original (PDF) on 24 January 2009. Retrieved 8 Sep 2008.
  • ^ a b c "Dietoterapia del síndrome nefrótico". Archived from the original on 2009-01-22. Retrieved 8 Sep 2008.
  • ^ "Lista de alimentos ricos en sodio". Retrieved 8 Sep 2008.
  • ^ "Fluidoterapia: tipos de expansores" (PDF). Archived from the original (PDF) on 2008-09-20. Retrieved 8 Sep 2008. Plasma expanders are natural or synthetic substances (dextran, albumin...), that are able to retain liquid in the vascular space.
  • ^ "Lista de alimentos ricos en proteínas". Archived from the original on 7 September 2008. Retrieved 8 Sep 2008. Expressed as grams per 100 g of food.
  • ^ "Sustitución de los alimentos ricos en grasas de la dieta". Archived from the original on February 12, 2008. Retrieved 8 Sep 2008. Organizations in the US recommend that no more than 30% of total daily calorie intake is from fats.
  • ^ Martín Zurro, Armando (2005). "Hipolipemiante, diuréticos, estatina.". Compendio de atención primaria: Conceptos, organización y práctica clínica (Segunda ed.). Elsevier España. p. 794. ISBN 8481748161.
  • ^ Jiménez Alonso, Juan. "Profilaxis de los fenómenos tromboembólicos" (PDF). Retrieved 2008-09-14.[permanent dead link]
  • ^ Glassock RJ (August 2007). "Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum". J. Am. Soc. Nephrol. 18 (8): 2221–5. doi:10.1681/ASN.2006111300. PMID 17599972.
  • ^ "Rango Internacional Normalizado (INR)". Retrieved 2008-09-14.
  • ^ "Tratamiento de la hipercoagulabilidad". Archived from the original on 2008-09-15. Retrieved 2008-09-14.
  • ^ "Tratamiento de la hipocalcemia". Archived from the original on 2008-09-15. Retrieved 2008-09-14.
  • ^ Hahn D, Hodson EM, Willis NS, Craig JC (2015). "Corticosteroid therapy for nephrotic syndrome in children". Cochrane Database of Systematic Reviews. 2015 (3): CD001533. doi:10.1002/14651858.CD001533.pub5. PMC 7025788. PMID 25785660.
  • ^ According to MedlinePlus, avascular necrosis is the death of the bone caused by insufficient blood supply to the bone.
  • ^ Cuzzoni, E; De Iudicibus, S; Stocco, G; Favretto, D (2016). "In Vitro sensitivity to methyl-prednisolone is associated with clinical response in pediatric idiopathic nephrotic syndrome". Clin Pharmacol Ther. 100 (3): 268–74. doi:10.1002/cpt.372. hdl:11368/2878528. PMID 27007551. S2CID 37671642.
  • ^ a b Guerrero Fernández, J. "Pronóstico de la enfermedad". Retrieved 2016-05-21.
  • ^ "Síndrome nefrótico idiopático: diagnóstico histológico por biopsia renal percutanea". 1995. Archived from the original on 2016-03-25. Retrieved 2016-05-21.
  • ^ a b c d Borrego R., Jaime; Montero C., Orlando (2003). Nefrología: Fundamentos de medicina (Cuarta ed.). Corporación para investigaciones biológicas. p. 340. ISBN 9589400639.
  • External links[edit]


    Retrieved from "https://en.wikipedia.org/w/index.php?title=Nephrotic_syndrome&oldid=1220842687"

    Categories: 
    Kidney diseases
    Pediatrics
    Syndromes affecting the kidneys
    Disorders causing edema
    Hidden categories: 
    CS1 Spanish-language sources (es)
    All articles with dead external links
    Articles with dead external links from August 2018
    Articles with permanently dead external links
    CS1 maint: bot: original URL status unknown
    Articles with dead external links from December 2018
    Articles with dead external links from May 2017
    Articles with short description
    Short description is different from Wikidata
    All articles with unsourced statements
    Articles with unsourced statements from April 2021
    Articles with unsourced statements from November 2021
    Articles with BNF identifiers
    Articles with BNFdata identifiers
    Articles with J9U identifiers
    Articles with LCCN identifiers
    Articles with NDL identifiers
    Articles with NKC identifiers
    Wikipedia medicine articles ready to translate
     



    This page was last edited on 26 April 2024, at 07:17 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki